Form 8-K - Current report:
SEC Accession No. 0001062993-25-001745
Filing Date
2025-02-05
Accepted
2025-02-05 17:01:13
Documents
17
Period of Report
2025-01-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm   iXBRL 8-K 19083
2 EXHIBIT 10.1 exhibit10-1.htm EX-10.1 58012
3 EXHIBIT 10.2 exhibit10-2.htm EX-10.2 14979
  Complete submission text file 0001062993-25-001745.txt   333418

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flgc-20250130.xsd EX-101.SCH 4687
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT flgc-20250130_cal.xml EX-101.CAL 698
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT flgc-20250130_def.xml EX-101.DEF 22562
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flgc-20250130_lab.xml EX-101.LAB 47263
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flgc-20250130_pre.xml EX-101.PRE 25251
20 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 3286
Mailing Address 3230 W. COMMERCIAL BOULEVARD SUITE 180 FORT LAUDERDALE FL 33309
Business Address 3230 W. COMMERCIAL BOULEVARD SUITE 180 FORT LAUDERDALE FL 33309 416-861-2267
Flora Growth Corp. (Filer) CIK: 0001790169 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40397 | Film No.: 25594198
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)